Skip to main content
. Author manuscript; available in PMC: 2015 Sep 11.
Published in final edited form as: Curr Neurovasc Res. 2015;12(4):404–413. doi: 10.2174/1567202612666150807112524

Table 1. FoxO Transcription Factors and Diabetes Mellitus.

FoxO Proteins Biology
Expression and Structure FoxO proteins possess a butterfly-like appearance on X-ray crystallography and nuclear magnetic resonance
FoxO proteins are present throughout the body and have a conserved forkhead domain described as a “winged helix”
Post -Translational Modification FoxO proteins are modified by phosphorylation, acetylation, and ubiquitylation through pathways involving Akt, SgK, SIRT1, and Wnt signaling with WISP1
Akt and SgK phosphorylate FoxO proteins at different sites affording various pathways to control FoxO protein activity
Programmed Cell Death Under some conditions, the activation of FoxO proteins may prevent apoptotic cellular injury during oxidative stress
FoxO protein activation can lead to the induction of autophagy and increase cell survival, such as during the clearance of toxic mHtt protein in neurons and during starvation to maintain cardiac function
However, activation of FoxO proteins usually leads to apoptotic membrane PS externalization and DNA degradation. In some circumstances, a reduction in autophagy is required to block oxidative stress injury
Cellular Signaling Wnt signaling can promote cellular protection against apoptotic cell death through the inactivation of FoxO proteins
WISP1 can limit FoxO3a activity, block caspase 1 and 3 activity, and promote SIRT1 nuclear trafficking
FoxO proteins can control SIRT1 transcription and increase SIRT1 expression. In addition, SIRT1 promotes FoxO-driven SIRT1 autotranscription through the activation and deacetylation of FoxO proteins
Agents that are protective during DM, such as EPO and nicotinamide, can phosphorylate and inactive FoxO proteins to lead to cellular protection
Outcomes with Diabetes Mellitus Some clinical studies suggest a detrimental effect associated with FoxO proteins and DM
Inactivation of FoxO proteins during DM may protect pancreatic β-cells, retinal cells, renal cells, and glucose homeostasis
In some clinical populations, FoxO protein activation may be protective during metabolic disorders for the immune system, assist with insulin signaling, and maintain energy reserves

Akt: protein kinase B; DM: diabetes mellitus; DNA: deoxyribonucleic acid; EPO: erythropoietin; FoxO: mammalian forkhead transcription factors of the O class; mHtt: mutant Huntingtin; PS: phosphatidylserine; SgK: serum- and glucocorticoid-inducible protein kinase; SIRT1: silent mating type information regulation 2 homolog 1 (S. cerevisiae); WISP1: wnt1 inducible signaling pathway protein 1; Wnt: proteins derived from the Drosophila Wingless (Wg) and the mouse Int-1 genes